Leukemia, Myelodysplasia, Transplantation
News
How cancer patients make treatment decisions
patient and her father Photo by Rhoda Baer A survey of more than 5000 cancer patients suggests there are a number of factors that might make a...
Conference Coverage
Ibrutinib demonstrates efficacy in CLL after allo-HSCT
Photo courtesy of CDC SAN DIEGO—Ibrutinib can produce favorable results in heavily pretreated patients with chronic lymphocytic leukemia (CLL)...
News
Evolutionary findings may aid cancer drug development
Photo by Darren Baker By tracking the evolution of Abl and Src, investigators have made discoveries that may aid the design of highly specific...
Conference Coverage
Predicting outcomes of allo-HSCT in ALL
Photo by Chad McNeeley SAN DIEGO—A retrospective study has revealed a few factors that may predict outcomes of allogeneic hematopoietic stem cell...
From the Editor
Recognition of latest CLL therapies highlights new options for other cancers
News
Neural stem cells may fight chemo brain
Photo by Janet Stevens Human neural stem cell treatments are showing promise for reversing learning and memory deficits after chemotherapy,...
News
CRT may pose long-term risk of hormone deficiencies
Photo by Bill Branson New research indicates that patients who undergo cranial radiotherapy (CRT) for pediatric cancer may have an increased risk...
News
Leukemia, lymphoma cause more distress in young adults
patient and her father Photo by Rhoda Baer Results of 2 new studies indicate that young adults (ages 18 to 39) who have survived leukemia or...
News
Cancer patients rarely make inappropriate requests, study shows
Photo courtesy of NIH Although it makes sense that patient requests might drive physicians to practice defensive medicine, new research suggests...
News
Signs may predict death in cancer patients
Researchers have identified 8 highly specific physical and cognitive signs that seem to be associated with imminent death in cancer patients. The...
News
Approved TKI could treat drug-resistant CML, ALL
Photo courtesy of CDC New research indicates that a tyrosine kinase inhibitor (TKI) approved to treat advanced renal cell carcinoma could prove...